74 Note 26.12 Disclosure requirement under MSMED Act, 2006 The Company has certain dues to suppliers (trade payables) registered under Micro, Small and Medium Enterprises Development Act, 2006 (MSMED Act ). The disclosures pursuant to the said MSMED Act are as follows: (` lakhs) Particulars As at March 31, 2020 As at March 31, 2019 Principal amount due to suppliers registered under the MSMED Act and remaining unpaid as at year end 1.59 4.25 Interest due to suppliers registered under the MSMED Act and remaining unpaid as at year end 0.00 0.00 Principal amounts paid to suppliers registered under the MSMED Act, beyond the appointed day during the year 3.14 2.41 Interest due and payable towards suppliers registered under MSMED Act, for payments already made 1.37 1.37 Above disclosures have been made based on information available with the Company, for suppliers who are registered as Micro, Small and Medium Enterprise under ‘The Micro, Small and Medium Enterprise Development Act, 2006’ as at March 31, 2020. The Auditors have relied upon in respect of this matter. Note 26.13 Corporate Social Responsibility a) Gross amount required to be spent by the Company during the year is ` 30.10 lakhs b) Amount spent during the year on: (` lakhs) Particulars Paid Payable Total i) Construction | acquisition of any asset - - - ii) On purposes other than (i) above 30.10 - 30.10 Note 26.14 Regrouped | Recast | Reclassified Figures of the earlier year have been regrouped | recast | reclassified wherever necessary. Note 26.15 The Financial Statements were authorised for issue by the Board of Directors on April 24, 2020. In terms of our report attached For and on behalf of the Board of Directors For Deloitte Haskins & Sells LLP Wolfgang Schumann Chartered Accountants Chairman Samir R. Shah Rajas Khaladkar G Venugopala Rao Partner Chief Financial Officer Managing Director Mumbai Rakesh Pathak Atul April 24, 2020 Company Secretary April 24, 2020
RkJQdWJsaXNoZXIy MjA2MDI2